Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Celsion Corp (CLSN)

Celsion Corp (CLSN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Celsion Corp 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648 USA

P: 609-896-9100 F: 609-896-2200

Description:

Celsion is dedicated to the development and commercialization of oncology drugs including tumor-targeting treatments using focused heat energy in combination with heat activated drug delivery systems. Celsion has research, license or commercialization agreements with leading institutions such as the National Institutes of Health, Duke University Medical Center, University of Hong Kong, North Shore Long Island Jewish Health System.

Key Statistics

Overview:

Market Capitalization, $K 73,579
Shares Outstanding, K 75,019
Annual Sales, $ 500 K
Annual Net Income, $ -21,480 K
Last Quarter Sales, $ 130 K
Last Quarter Net Income, $ -3,010 K
60-Month Beta 2.04
% of Insider Shareholders 20.49%
% of Institutional Shareholders 4.26%
Float, K 59,648
% Float 79.51%

Growth:

1-Year Return -12.17%
3-Year Return -57.17%
5-Year Return -95.27%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 95.84%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 05/21/21
Earnings Per Share ttm -0.60
EPS Growth vs. Prev Qtr 70.59%
EPS Growth vs. Prev Year 50.00%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00
Most Recent Split 1-14 on 05/30/17

CLSN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -2.38
Price/Earnings to Growth N/A
Return-on-Equity % -98.42%
Return-on-Assets % -47.65%
Profit Margin % -4,296.00
Net Margin % N/A
Debt/Equity 0.21
Price/Sales 165.04
Price/Cash Flow N/A
Price/Book 2.60
Book Value/Share 0.46
Interest Coverage -17.09
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar